Solid Biosciences is trading 5% up today at $8.45 amid a broader rally in the biotech sector and equity markets.
- The stock is extending its recent upward trend following a sharp move higher in July and is currently sitting near its 52-week highs.
- With no fresh company-specific news or filings today, the move appears driven by strong risk-on sentiment, with the XBI biotech ETF and major U.S. indices all rallying more than 2%.